SARASOTA, Fla., July 12 /PRNewswire-FirstCall/ -- DNAPrint genomics, Inc. (OTC Bulletin Board: DNAG - News) today announced an upgrade in the throughput and cost efficiency of its automated Beckman Coulter GenomeLab SNPstream genotyping platform. Beckman Coulter, which manufactures laboratory instrument systems for diagnostic tests and biological research, upgraded DNAPrint's SNPstream Ultra High Throughput (UHT) instrument from 12-plex to 48-plex capability, allowing for an approximate four-fold increase in throughput, or the rate at which it can read DNA sequences. The instrument reads DNA sequence from microarray slides (so-called DNA chips) containing about 18,000 nanospots. Since the upgrade in capability does not require commensurate increases in labor, the Company expects to enjoy a significant reduction in price per genotype. The upgrade was part of a planned expansion of DNAPrint's laboratory size, presence and capabilities as the Company grows to handle larger numbers of drug and diagnostics development projects.